Hyperion Makes RAVICTI(TM) Available for Shipment to UCD Patients

[at noodls] – SOUTH SAN FRANCISCO, Calif., Feb. 28, 2013 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that RAVICTIâ„¢ (glycerol phenylbutyrate) Liquid is now available for shipment to … more

View todays social media effects on HPTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Hyperion is hiring next, click here to view